nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—hepatitis B—liver cancer	0.613	1	CtDrD
Lamivudine—ABCC4—Sorafenib—liver cancer	0.0431	0.188	CbGbCtD
Lamivudine—ABCC1—Epirubicin—liver cancer	0.0395	0.172	CbGbCtD
Lamivudine—ABCC3—Doxorubicin—liver cancer	0.0342	0.149	CbGbCtD
Lamivudine—ABCC2—Sorafenib—liver cancer	0.0256	0.112	CbGbCtD
Lamivudine—ABCG2—Sorafenib—liver cancer	0.0232	0.101	CbGbCtD
Lamivudine—ABCC1—Doxorubicin—liver cancer	0.021	0.0915	CbGbCtD
Lamivudine—ABCC2—Doxorubicin—liver cancer	0.0155	0.0677	CbGbCtD
Lamivudine—ABCG2—Doxorubicin—liver cancer	0.0141	0.0612	CbGbCtD
Lamivudine—ABCC2—bile canaliculus—liver cancer	0.0126	0.328	CbGeAlD
Lamivudine—ABCB1—Sorafenib—liver cancer	0.00835	0.0364	CbGbCtD
Lamivudine—ABCB1—Doxorubicin—liver cancer	0.00507	0.0221	CbGbCtD
Lamivudine—ABCC3—bile duct—liver cancer	0.00492	0.128	CbGeAlD
Lamivudine—ABCC2—bile duct—liver cancer	0.00393	0.102	CbGeAlD
Lamivudine—ABCC2—bile—liver cancer	0.00302	0.0787	CbGeAlD
Lamivudine—PCYT2—liver—liver cancer	0.00147	0.0383	CbGeAlD
Lamivudine—NME2—embryo—liver cancer	0.00137	0.0355	CbGeAlD
Lamivudine—PGK1—liver—liver cancer	0.00127	0.0329	CbGeAlD
Lamivudine—NME1-NME2—liver—liver cancer	0.00115	0.03	CbGeAlD
Lamivudine—NT5C—liver—liver cancer	0.00107	0.0278	CbGeAlD
Lamivudine—ABCC3—gall bladder—liver cancer	0.00105	0.0273	CbGeAlD
Lamivudine—PCYT1A—liver—liver cancer	0.001	0.0261	CbGeAlD
Lamivudine—DCK—embryo—liver cancer	0.000695	0.0181	CbGeAlD
Lamivudine—NME1—liver—liver cancer	0.00067	0.0175	CbGeAlD
Lamivudine—CMPK1—liver—liver cancer	0.000646	0.0168	CbGeAlD
Lamivudine—NME2—liver—liver cancer	0.000631	0.0164	CbGeAlD
Lamivudine—DCK—Doxorubicin—Epirubicin—liver cancer	0.000589	0.519	CbGdCrCtD
Lamivudine—SLC22A3—embryo—liver cancer	0.000567	0.0148	CbGeAlD
Lamivudine—DCK—Epirubicin—Doxorubicin—liver cancer	0.000545	0.481	CbGdCrCtD
Lamivudine—DCK—liver—liver cancer	0.000322	0.00838	CbGeAlD
Lamivudine—ABCC3—liver—liver cancer	0.000308	0.00802	CbGeAlD
Lamivudine—SLC22A1—liver—liver cancer	0.000274	0.00714	CbGeAlD
Lamivudine—SLC22A3—liver—liver cancer	0.000262	0.00683	CbGeAlD
Lamivudine—ABCC4—liver—liver cancer	0.000254	0.00662	CbGeAlD
Lamivudine—ABCC2—liver—liver cancer	0.000246	0.00641	CbGeAlD
Lamivudine—ABCC1—liver—liver cancer	0.000217	0.00564	CbGeAlD
Lamivudine—ABCB1—embryo—liver cancer	0.000191	0.00498	CbGeAlD
Lamivudine—ABCG2—liver—liver cancer	0.000179	0.00467	CbGeAlD
Lamivudine—Anaphylactic shock—Sorafenib—liver cancer	0.000177	0.00338	CcSEcCtD
Lamivudine—Infection—Sorafenib—liver cancer	0.000176	0.00335	CcSEcCtD
Lamivudine—Inflammation—Doxorubicin—liver cancer	0.000175	0.00334	CcSEcCtD
Lamivudine—Shock—Sorafenib—liver cancer	0.000174	0.00332	CcSEcCtD
Lamivudine—Nervous system disorder—Sorafenib—liver cancer	0.000174	0.00331	CcSEcCtD
Lamivudine—Thrombocytopenia—Sorafenib—liver cancer	0.000174	0.00331	CcSEcCtD
Lamivudine—Neuropathy—Epirubicin—liver cancer	0.000172	0.00328	CcSEcCtD
Lamivudine—Aplastic anaemia—Epirubicin—liver cancer	0.000172	0.00328	CcSEcCtD
Lamivudine—Skin disorder—Sorafenib—liver cancer	0.000172	0.00328	CcSEcCtD
Lamivudine—Musculoskeletal pain—Doxorubicin—liver cancer	0.000172	0.00328	CcSEcCtD
Lamivudine—Anorexia—Sorafenib—liver cancer	0.000169	0.00322	CcSEcCtD
Lamivudine—Eructation—Doxorubicin—liver cancer	0.000167	0.00318	CcSEcCtD
Lamivudine—Mouth ulceration—Epirubicin—liver cancer	0.000166	0.00316	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000162	0.00308	CcSEcCtD
Lamivudine—Neuropathy—Doxorubicin—liver cancer	0.00016	0.00304	CcSEcCtD
Lamivudine—Aplastic anaemia—Doxorubicin—liver cancer	0.00016	0.00304	CcSEcCtD
Lamivudine—Sepsis—Epirubicin—liver cancer	0.000159	0.00303	CcSEcCtD
Lamivudine—Dyspnoea—Sorafenib—liver cancer	0.000158	0.00301	CcSEcCtD
Lamivudine—Lymphadenopathy—Epirubicin—liver cancer	0.000156	0.00298	CcSEcCtD
Lamivudine—Dyspepsia—Sorafenib—liver cancer	0.000156	0.00297	CcSEcCtD
Lamivudine—Phlebitis—Epirubicin—liver cancer	0.000155	0.00295	CcSEcCtD
Lamivudine—Decreased appetite—Sorafenib—liver cancer	0.000154	0.00293	CcSEcCtD
Lamivudine—Mouth ulceration—Doxorubicin—liver cancer	0.000154	0.00293	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000153	0.00291	CcSEcCtD
Lamivudine—Fatigue—Sorafenib—liver cancer	0.000153	0.00291	CcSEcCtD
Lamivudine—Constipation—Sorafenib—liver cancer	0.000152	0.00289	CcSEcCtD
Lamivudine—Pain—Sorafenib—liver cancer	0.000152	0.00289	CcSEcCtD
Lamivudine—Sepsis—Doxorubicin—liver cancer	0.000148	0.00281	CcSEcCtD
Lamivudine—Gastrointestinal pain—Sorafenib—liver cancer	0.000145	0.00276	CcSEcCtD
Lamivudine—Lymphadenopathy—Doxorubicin—liver cancer	0.000145	0.00275	CcSEcCtD
Lamivudine—Phlebitis—Doxorubicin—liver cancer	0.000143	0.00273	CcSEcCtD
Lamivudine—Urticaria—Sorafenib—liver cancer	0.000141	0.00268	CcSEcCtD
Lamivudine—Abdominal pain—Sorafenib—liver cancer	0.00014	0.00267	CcSEcCtD
Lamivudine—Body temperature increased—Sorafenib—liver cancer	0.00014	0.00267	CcSEcCtD
Lamivudine—Renal impairment—Epirubicin—liver cancer	0.00014	0.00267	CcSEcCtD
Lamivudine—Hypoglycaemia—Epirubicin—liver cancer	0.000137	0.0026	CcSEcCtD
Lamivudine—Migraine—Epirubicin—liver cancer	0.000131	0.0025	CcSEcCtD
Lamivudine—Affect lability—Epirubicin—liver cancer	0.000131	0.0025	CcSEcCtD
Lamivudine—Hypersensitivity—Sorafenib—liver cancer	0.000131	0.00249	CcSEcCtD
Lamivudine—Renal impairment—Doxorubicin—liver cancer	0.00013	0.00247	CcSEcCtD
Lamivudine—Asthenia—Sorafenib—liver cancer	0.000127	0.00242	CcSEcCtD
Lamivudine—Hypoglycaemia—Doxorubicin—liver cancer	0.000126	0.00241	CcSEcCtD
Lamivudine—Mood swings—Epirubicin—liver cancer	0.000126	0.0024	CcSEcCtD
Lamivudine—Pruritus—Sorafenib—liver cancer	0.000125	0.00239	CcSEcCtD
Lamivudine—Dehydration—Epirubicin—liver cancer	0.000124	0.00236	CcSEcCtD
Lamivudine—Liver function test abnormal—Epirubicin—liver cancer	0.000123	0.00234	CcSEcCtD
Lamivudine—Abdominal pain upper—Epirubicin—liver cancer	0.000122	0.00232	CcSEcCtD
Lamivudine—Migraine—Doxorubicin—liver cancer	0.000121	0.00231	CcSEcCtD
Lamivudine—Affect lability—Doxorubicin—liver cancer	0.000121	0.00231	CcSEcCtD
Lamivudine—Diarrhoea—Sorafenib—liver cancer	0.000121	0.00231	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00012	0.00229	CcSEcCtD
Lamivudine—Nasopharyngitis—Epirubicin—liver cancer	0.000119	0.00227	CcSEcCtD
Lamivudine—Muscular weakness—Epirubicin—liver cancer	0.000118	0.00224	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000118	0.00224	CcSEcCtD
Lamivudine—Dizziness—Sorafenib—liver cancer	0.000117	0.00223	CcSEcCtD
Lamivudine—Mood swings—Doxorubicin—liver cancer	0.000117	0.00223	CcSEcCtD
Lamivudine—Abdominal distension—Epirubicin—liver cancer	0.000116	0.00221	CcSEcCtD
Lamivudine—Influenza—Epirubicin—liver cancer	0.000115	0.00219	CcSEcCtD
Lamivudine—Dysphagia—Epirubicin—liver cancer	0.000115	0.00219	CcSEcCtD
Lamivudine—Dehydration—Doxorubicin—liver cancer	0.000115	0.00218	CcSEcCtD
Lamivudine—Liver function test abnormal—Doxorubicin—liver cancer	0.000114	0.00217	CcSEcCtD
Lamivudine—Pancreatitis—Epirubicin—liver cancer	0.000113	0.00215	CcSEcCtD
Lamivudine—Vomiting—Sorafenib—liver cancer	0.000113	0.00215	CcSEcCtD
Lamivudine—Abdominal pain upper—Doxorubicin—liver cancer	0.000113	0.00215	CcSEcCtD
Lamivudine—Rash—Sorafenib—liver cancer	0.000112	0.00213	CcSEcCtD
Lamivudine—Dermatitis—Sorafenib—liver cancer	0.000112	0.00213	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000111	0.00212	CcSEcCtD
Lamivudine—Headache—Sorafenib—liver cancer	0.000111	0.00211	CcSEcCtD
Lamivudine—Bronchitis—Epirubicin—liver cancer	0.000111	0.00211	CcSEcCtD
Lamivudine—Nasopharyngitis—Doxorubicin—liver cancer	0.00011	0.0021	CcSEcCtD
Lamivudine—Pancytopenia—Epirubicin—liver cancer	0.000109	0.00208	CcSEcCtD
Lamivudine—Muscular weakness—Doxorubicin—liver cancer	0.000109	0.00207	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000109	0.00207	CcSEcCtD
Lamivudine—Dysuria—Epirubicin—liver cancer	0.000108	0.00205	CcSEcCtD
Lamivudine—Neutropenia—Epirubicin—liver cancer	0.000108	0.00205	CcSEcCtD
Lamivudine—Abdominal distension—Doxorubicin—liver cancer	0.000107	0.00204	CcSEcCtD
Lamivudine—Dysphagia—Doxorubicin—liver cancer	0.000107	0.00203	CcSEcCtD
Lamivudine—Influenza—Doxorubicin—liver cancer	0.000107	0.00203	CcSEcCtD
Lamivudine—Pollakiuria—Epirubicin—liver cancer	0.000106	0.00203	CcSEcCtD
Lamivudine—Nausea—Sorafenib—liver cancer	0.000105	0.00201	CcSEcCtD
Lamivudine—Pancreatitis—Doxorubicin—liver cancer	0.000105	0.00199	CcSEcCtD
Lamivudine—Hyperglycaemia—Epirubicin—liver cancer	0.000104	0.00198	CcSEcCtD
Lamivudine—Bronchitis—Doxorubicin—liver cancer	0.000103	0.00195	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000102	0.00194	CcSEcCtD
Lamivudine—Pancytopenia—Doxorubicin—liver cancer	0.000101	0.00193	CcSEcCtD
Lamivudine—Renal failure—Epirubicin—liver cancer	0.000101	0.00192	CcSEcCtD
Lamivudine—Neuropathy peripheral—Epirubicin—liver cancer	0.000101	0.00192	CcSEcCtD
Lamivudine—Jaundice—Epirubicin—liver cancer	0.0001	0.00191	CcSEcCtD
Lamivudine—Stomatitis—Epirubicin—liver cancer	0.0001	0.00191	CcSEcCtD
Lamivudine—Dysuria—Doxorubicin—liver cancer	9.97e-05	0.0019	CcSEcCtD
Lamivudine—Neutropenia—Doxorubicin—liver cancer	9.97e-05	0.0019	CcSEcCtD
Lamivudine—Sweating—Epirubicin—liver cancer	9.85e-05	0.00188	CcSEcCtD
Lamivudine—Pollakiuria—Doxorubicin—liver cancer	9.85e-05	0.00188	CcSEcCtD
Lamivudine—Hepatobiliary disease—Epirubicin—liver cancer	9.72e-05	0.00185	CcSEcCtD
Lamivudine—Epistaxis—Epirubicin—liver cancer	9.69e-05	0.00185	CcSEcCtD
Lamivudine—Sinusitis—Epirubicin—liver cancer	9.64e-05	0.00184	CcSEcCtD
Lamivudine—Hyperglycaemia—Doxorubicin—liver cancer	9.62e-05	0.00183	CcSEcCtD
Lamivudine—Agranulocytosis—Epirubicin—liver cancer	9.59e-05	0.00183	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	9.43e-05	0.00179	CcSEcCtD
Lamivudine—Renal failure—Doxorubicin—liver cancer	9.35e-05	0.00178	CcSEcCtD
Lamivudine—Neuropathy peripheral—Doxorubicin—liver cancer	9.32e-05	0.00177	CcSEcCtD
Lamivudine—Jaundice—Doxorubicin—liver cancer	9.27e-05	0.00176	CcSEcCtD
Lamivudine—Stomatitis—Doxorubicin—liver cancer	9.27e-05	0.00176	CcSEcCtD
Lamivudine—Rhinitis—Epirubicin—liver cancer	9.25e-05	0.00176	CcSEcCtD
Lamivudine—Hepatitis—Epirubicin—liver cancer	9.23e-05	0.00176	CcSEcCtD
Lamivudine—Hypoaesthesia—Epirubicin—liver cancer	9.18e-05	0.00175	CcSEcCtD
Lamivudine—Pharyngitis—Epirubicin—liver cancer	9.16e-05	0.00174	CcSEcCtD
Lamivudine—Sweating—Doxorubicin—liver cancer	9.12e-05	0.00174	CcSEcCtD
Lamivudine—Connective tissue disorder—Epirubicin—liver cancer	9.07e-05	0.00173	CcSEcCtD
Lamivudine—Hepatobiliary disease—Doxorubicin—liver cancer	8.99e-05	0.00171	CcSEcCtD
Lamivudine—Epistaxis—Doxorubicin—liver cancer	8.97e-05	0.00171	CcSEcCtD
Lamivudine—Sinusitis—Doxorubicin—liver cancer	8.92e-05	0.0017	CcSEcCtD
Lamivudine—Agranulocytosis—Doxorubicin—liver cancer	8.87e-05	0.00169	CcSEcCtD
Lamivudine—ABCB1—liver—liver cancer	8.85e-05	0.0023	CbGeAlD
Lamivudine—Erythema multiforme—Epirubicin—liver cancer	8.72e-05	0.00166	CcSEcCtD
Lamivudine—Rhinitis—Doxorubicin—liver cancer	8.56e-05	0.00163	CcSEcCtD
Lamivudine—Hepatitis—Doxorubicin—liver cancer	8.54e-05	0.00162	CcSEcCtD
Lamivudine—Hypoaesthesia—Doxorubicin—liver cancer	8.49e-05	0.00162	CcSEcCtD
Lamivudine—Pharyngitis—Doxorubicin—liver cancer	8.47e-05	0.00161	CcSEcCtD
Lamivudine—Connective tissue disorder—Doxorubicin—liver cancer	8.39e-05	0.0016	CcSEcCtD
Lamivudine—Immune system disorder—Epirubicin—liver cancer	8.33e-05	0.00159	CcSEcCtD
Lamivudine—Mediastinal disorder—Epirubicin—liver cancer	8.31e-05	0.00158	CcSEcCtD
Lamivudine—Chills—Epirubicin—liver cancer	8.28e-05	0.00158	CcSEcCtD
Lamivudine—Alopecia—Epirubicin—liver cancer	8.15e-05	0.00155	CcSEcCtD
Lamivudine—Erythema multiforme—Doxorubicin—liver cancer	8.07e-05	0.00154	CcSEcCtD
Lamivudine—Malnutrition—Epirubicin—liver cancer	8.03e-05	0.00153	CcSEcCtD
Lamivudine—Erythema—Epirubicin—liver cancer	8.03e-05	0.00153	CcSEcCtD
Lamivudine—Flatulence—Epirubicin—liver cancer	7.91e-05	0.00151	CcSEcCtD
Lamivudine—Tension—Epirubicin—liver cancer	7.88e-05	0.0015	CcSEcCtD
Lamivudine—Dysgeusia—Epirubicin—liver cancer	7.86e-05	0.0015	CcSEcCtD
Lamivudine—Nervousness—Epirubicin—liver cancer	7.8e-05	0.00148	CcSEcCtD
Lamivudine—Back pain—Epirubicin—liver cancer	7.77e-05	0.00148	CcSEcCtD
Lamivudine—Muscle spasms—Epirubicin—liver cancer	7.72e-05	0.00147	CcSEcCtD
Lamivudine—Immune system disorder—Doxorubicin—liver cancer	7.71e-05	0.00147	CcSEcCtD
Lamivudine—Mediastinal disorder—Doxorubicin—liver cancer	7.69e-05	0.00146	CcSEcCtD
Lamivudine—Chills—Doxorubicin—liver cancer	7.66e-05	0.00146	CcSEcCtD
Lamivudine—Alopecia—Doxorubicin—liver cancer	7.54e-05	0.00144	CcSEcCtD
Lamivudine—Ill-defined disorder—Epirubicin—liver cancer	7.45e-05	0.00142	CcSEcCtD
Lamivudine—Malnutrition—Doxorubicin—liver cancer	7.43e-05	0.00141	CcSEcCtD
Lamivudine—Erythema—Doxorubicin—liver cancer	7.43e-05	0.00141	CcSEcCtD
Lamivudine—Anaemia—Epirubicin—liver cancer	7.42e-05	0.00141	CcSEcCtD
Lamivudine—Flatulence—Doxorubicin—liver cancer	7.32e-05	0.00139	CcSEcCtD
Lamivudine—Tension—Doxorubicin—liver cancer	7.29e-05	0.00139	CcSEcCtD
Lamivudine—Dysgeusia—Doxorubicin—liver cancer	7.28e-05	0.00139	CcSEcCtD
Lamivudine—Malaise—Epirubicin—liver cancer	7.24e-05	0.00138	CcSEcCtD
Lamivudine—Nervousness—Doxorubicin—liver cancer	7.22e-05	0.00137	CcSEcCtD
Lamivudine—Vertigo—Epirubicin—liver cancer	7.22e-05	0.00137	CcSEcCtD
Lamivudine—Syncope—Epirubicin—liver cancer	7.2e-05	0.00137	CcSEcCtD
Lamivudine—Leukopenia—Epirubicin—liver cancer	7.19e-05	0.00137	CcSEcCtD
Lamivudine—Back pain—Doxorubicin—liver cancer	7.19e-05	0.00137	CcSEcCtD
Lamivudine—Muscle spasms—Doxorubicin—liver cancer	7.14e-05	0.00136	CcSEcCtD
Lamivudine—Loss of consciousness—Epirubicin—liver cancer	7.06e-05	0.00134	CcSEcCtD
Lamivudine—Cough—Epirubicin—liver cancer	7.01e-05	0.00133	CcSEcCtD
Lamivudine—Convulsion—Epirubicin—liver cancer	6.96e-05	0.00132	CcSEcCtD
Lamivudine—Ill-defined disorder—Doxorubicin—liver cancer	6.89e-05	0.00131	CcSEcCtD
Lamivudine—Anaemia—Doxorubicin—liver cancer	6.87e-05	0.00131	CcSEcCtD
Lamivudine—Chest pain—Epirubicin—liver cancer	6.84e-05	0.0013	CcSEcCtD
Lamivudine—Myalgia—Epirubicin—liver cancer	6.84e-05	0.0013	CcSEcCtD
Lamivudine—Arthralgia—Epirubicin—liver cancer	6.84e-05	0.0013	CcSEcCtD
Lamivudine—Anxiety—Epirubicin—liver cancer	6.81e-05	0.0013	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	6.79e-05	0.00129	CcSEcCtD
Lamivudine—Discomfort—Epirubicin—liver cancer	6.76e-05	0.00129	CcSEcCtD
Lamivudine—Malaise—Doxorubicin—liver cancer	6.7e-05	0.00128	CcSEcCtD
Lamivudine—Dry mouth—Epirubicin—liver cancer	6.69e-05	0.00127	CcSEcCtD
Lamivudine—Vertigo—Doxorubicin—liver cancer	6.68e-05	0.00127	CcSEcCtD
Lamivudine—Syncope—Doxorubicin—liver cancer	6.66e-05	0.00127	CcSEcCtD
Lamivudine—Leukopenia—Doxorubicin—liver cancer	6.65e-05	0.00127	CcSEcCtD
Lamivudine—Confusional state—Epirubicin—liver cancer	6.61e-05	0.00126	CcSEcCtD
Lamivudine—Anaphylactic shock—Epirubicin—liver cancer	6.55e-05	0.00125	CcSEcCtD
Lamivudine—Oedema—Epirubicin—liver cancer	6.55e-05	0.00125	CcSEcCtD
Lamivudine—Loss of consciousness—Doxorubicin—liver cancer	6.53e-05	0.00124	CcSEcCtD
Lamivudine—Infection—Epirubicin—liver cancer	6.51e-05	0.00124	CcSEcCtD
Lamivudine—Cough—Doxorubicin—liver cancer	6.48e-05	0.00123	CcSEcCtD
Lamivudine—Shock—Epirubicin—liver cancer	6.45e-05	0.00123	CcSEcCtD
Lamivudine—Convulsion—Doxorubicin—liver cancer	6.44e-05	0.00123	CcSEcCtD
Lamivudine—Nervous system disorder—Epirubicin—liver cancer	6.43e-05	0.00122	CcSEcCtD
Lamivudine—Thrombocytopenia—Epirubicin—liver cancer	6.42e-05	0.00122	CcSEcCtD
Lamivudine—Skin disorder—Epirubicin—liver cancer	6.37e-05	0.00121	CcSEcCtD
Lamivudine—Hyperhidrosis—Epirubicin—liver cancer	6.34e-05	0.00121	CcSEcCtD
Lamivudine—Arthralgia—Doxorubicin—liver cancer	6.33e-05	0.0012	CcSEcCtD
Lamivudine—Chest pain—Doxorubicin—liver cancer	6.33e-05	0.0012	CcSEcCtD
Lamivudine—Myalgia—Doxorubicin—liver cancer	6.33e-05	0.0012	CcSEcCtD
Lamivudine—Anxiety—Doxorubicin—liver cancer	6.3e-05	0.0012	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	6.28e-05	0.0012	CcSEcCtD
Lamivudine—Discomfort—Doxorubicin—liver cancer	6.25e-05	0.00119	CcSEcCtD
Lamivudine—Anorexia—Epirubicin—liver cancer	6.25e-05	0.00119	CcSEcCtD
Lamivudine—Dry mouth—Doxorubicin—liver cancer	6.19e-05	0.00118	CcSEcCtD
Lamivudine—Hypotension—Epirubicin—liver cancer	6.12e-05	0.00117	CcSEcCtD
Lamivudine—Confusional state—Doxorubicin—liver cancer	6.12e-05	0.00116	CcSEcCtD
Lamivudine—Anaphylactic shock—Doxorubicin—liver cancer	6.06e-05	0.00115	CcSEcCtD
Lamivudine—Oedema—Doxorubicin—liver cancer	6.06e-05	0.00115	CcSEcCtD
Lamivudine—Infection—Doxorubicin—liver cancer	6.02e-05	0.00115	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Epirubicin—liver cancer	5.97e-05	0.00114	CcSEcCtD
Lamivudine—Shock—Doxorubicin—liver cancer	5.97e-05	0.00114	CcSEcCtD
Lamivudine—Nervous system disorder—Doxorubicin—liver cancer	5.95e-05	0.00113	CcSEcCtD
Lamivudine—Thrombocytopenia—Doxorubicin—liver cancer	5.94e-05	0.00113	CcSEcCtD
Lamivudine—Insomnia—Epirubicin—liver cancer	5.93e-05	0.00113	CcSEcCtD
Lamivudine—Skin disorder—Doxorubicin—liver cancer	5.89e-05	0.00112	CcSEcCtD
Lamivudine—Paraesthesia—Epirubicin—liver cancer	5.89e-05	0.00112	CcSEcCtD
Lamivudine—Hyperhidrosis—Doxorubicin—liver cancer	5.86e-05	0.00112	CcSEcCtD
Lamivudine—Dyspnoea—Epirubicin—liver cancer	5.84e-05	0.00111	CcSEcCtD
Lamivudine—Somnolence—Epirubicin—liver cancer	5.83e-05	0.00111	CcSEcCtD
Lamivudine—Anorexia—Doxorubicin—liver cancer	5.78e-05	0.0011	CcSEcCtD
Lamivudine—Dyspepsia—Epirubicin—liver cancer	5.77e-05	0.0011	CcSEcCtD
Lamivudine—Decreased appetite—Epirubicin—liver cancer	5.7e-05	0.00108	CcSEcCtD
Lamivudine—Hypotension—Doxorubicin—liver cancer	5.67e-05	0.00108	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Epirubicin—liver cancer	5.66e-05	0.00108	CcSEcCtD
Lamivudine—Fatigue—Epirubicin—liver cancer	5.65e-05	0.00108	CcSEcCtD
Lamivudine—Pain—Epirubicin—liver cancer	5.6e-05	0.00107	CcSEcCtD
Lamivudine—Constipation—Epirubicin—liver cancer	5.6e-05	0.00107	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Doxorubicin—liver cancer	5.53e-05	0.00105	CcSEcCtD
Lamivudine—Insomnia—Doxorubicin—liver cancer	5.49e-05	0.00104	CcSEcCtD
Lamivudine—Paraesthesia—Doxorubicin—liver cancer	5.45e-05	0.00104	CcSEcCtD
Lamivudine—Dyspnoea—Doxorubicin—liver cancer	5.41e-05	0.00103	CcSEcCtD
Lamivudine—Feeling abnormal—Epirubicin—liver cancer	5.4e-05	0.00103	CcSEcCtD
Lamivudine—Somnolence—Doxorubicin—liver cancer	5.39e-05	0.00103	CcSEcCtD
Lamivudine—Gastrointestinal pain—Epirubicin—liver cancer	5.36e-05	0.00102	CcSEcCtD
Lamivudine—Dyspepsia—Doxorubicin—liver cancer	5.34e-05	0.00102	CcSEcCtD
Lamivudine—Decreased appetite—Doxorubicin—liver cancer	5.27e-05	0.001	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Doxorubicin—liver cancer	5.24e-05	0.000997	CcSEcCtD
Lamivudine—Fatigue—Doxorubicin—liver cancer	5.23e-05	0.000995	CcSEcCtD
Lamivudine—Urticaria—Epirubicin—liver cancer	5.21e-05	0.000991	CcSEcCtD
Lamivudine—Pain—Doxorubicin—liver cancer	5.19e-05	0.000987	CcSEcCtD
Lamivudine—Constipation—Doxorubicin—liver cancer	5.19e-05	0.000987	CcSEcCtD
Lamivudine—Abdominal pain—Epirubicin—liver cancer	5.18e-05	0.000986	CcSEcCtD
Lamivudine—Body temperature increased—Epirubicin—liver cancer	5.18e-05	0.000986	CcSEcCtD
Lamivudine—Feeling abnormal—Doxorubicin—liver cancer	5e-05	0.000951	CcSEcCtD
Lamivudine—Gastrointestinal pain—Doxorubicin—liver cancer	4.96e-05	0.000944	CcSEcCtD
Lamivudine—Hypersensitivity—Epirubicin—liver cancer	4.83e-05	0.000919	CcSEcCtD
Lamivudine—Urticaria—Doxorubicin—liver cancer	4.82e-05	0.000917	CcSEcCtD
Lamivudine—Abdominal pain—Doxorubicin—liver cancer	4.79e-05	0.000913	CcSEcCtD
Lamivudine—Body temperature increased—Doxorubicin—liver cancer	4.79e-05	0.000913	CcSEcCtD
Lamivudine—Asthenia—Epirubicin—liver cancer	4.7e-05	0.000895	CcSEcCtD
Lamivudine—Pruritus—Epirubicin—liver cancer	4.64e-05	0.000883	CcSEcCtD
Lamivudine—Diarrhoea—Epirubicin—liver cancer	4.48e-05	0.000854	CcSEcCtD
Lamivudine—Hypersensitivity—Doxorubicin—liver cancer	4.47e-05	0.000851	CcSEcCtD
Lamivudine—Asthenia—Doxorubicin—liver cancer	4.35e-05	0.000828	CcSEcCtD
Lamivudine—Dizziness—Epirubicin—liver cancer	4.33e-05	0.000825	CcSEcCtD
Lamivudine—Pruritus—Doxorubicin—liver cancer	4.29e-05	0.000817	CcSEcCtD
Lamivudine—Vomiting—Epirubicin—liver cancer	4.17e-05	0.000793	CcSEcCtD
Lamivudine—Diarrhoea—Doxorubicin—liver cancer	4.15e-05	0.00079	CcSEcCtD
Lamivudine—Rash—Epirubicin—liver cancer	4.13e-05	0.000787	CcSEcCtD
Lamivudine—Dermatitis—Epirubicin—liver cancer	4.13e-05	0.000786	CcSEcCtD
Lamivudine—Headache—Epirubicin—liver cancer	4.11e-05	0.000782	CcSEcCtD
Lamivudine—Dizziness—Doxorubicin—liver cancer	4.01e-05	0.000763	CcSEcCtD
Lamivudine—Nausea—Epirubicin—liver cancer	3.89e-05	0.000741	CcSEcCtD
Lamivudine—Vomiting—Doxorubicin—liver cancer	3.86e-05	0.000734	CcSEcCtD
Lamivudine—Rash—Doxorubicin—liver cancer	3.82e-05	0.000728	CcSEcCtD
Lamivudine—Dermatitis—Doxorubicin—liver cancer	3.82e-05	0.000727	CcSEcCtD
Lamivudine—Headache—Doxorubicin—liver cancer	3.8e-05	0.000723	CcSEcCtD
Lamivudine—Nausea—Doxorubicin—liver cancer	3.6e-05	0.000686	CcSEcCtD
Lamivudine—SLC22A3—Metabolism—GGT1—liver cancer	8.23e-06	0.000125	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GOT1—liver cancer	8.23e-06	0.000125	CbGpPWpGaD
Lamivudine—ABCC1—Disease—GOT2—liver cancer	8.2e-06	0.000125	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.16e-06	0.000124	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTA1—liver cancer	8.13e-06	0.000124	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ALB—liver cancer	8.08e-06	0.000123	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NAT2—liver cancer	8.04e-06	0.000122	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CG—liver cancer	7.99e-06	0.000121	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.98e-06	0.000121	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CRABP1—liver cancer	7.97e-06	0.000121	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—PPARA—liver cancer	7.97e-06	0.000121	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—liver cancer	7.96e-06	0.000121	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HPGDS—liver cancer	7.92e-06	0.00012	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CRABP1—liver cancer	7.89e-06	0.00012	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—PPARA—liver cancer	7.89e-06	0.00012	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.87e-06	0.00012	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PIK3CA—liver cancer	7.85e-06	0.000119	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—RAF1—liver cancer	7.77e-06	0.000118	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PPARG—liver cancer	7.71e-06	0.000117	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYCS—liver cancer	7.71e-06	0.000117	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALDOB—liver cancer	7.71e-06	0.000117	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IL2—liver cancer	7.57e-06	0.000115	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GGT1—liver cancer	7.56e-06	0.000115	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GOT1—liver cancer	7.56e-06	0.000115	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTP1—liver cancer	7.39e-06	0.000112	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CRABP1—liver cancer	7.35e-06	0.000112	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—PPARA—liver cancer	7.35e-06	0.000112	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—RAF1—liver cancer	7.3e-06	0.000111	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	7.29e-06	0.000111	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—HMOX1—liver cancer	7.29e-06	0.000111	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PIK3CA—liver cancer	7.18e-06	0.000109	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.17e-06	0.000109	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—liver cancer	7.09e-06	0.000108	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.08e-06	0.000108	CbGpPWpGaD
Lamivudine—ABCC1—Disease—GOT1—liver cancer	7.08e-06	0.000108	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PSMD10—liver cancer	7.06e-06	0.000107	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PSMA4—liver cancer	7.06e-06	0.000107	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	7.03e-06	0.000107	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CD—liver cancer	7.02e-06	0.000107	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HPGDS—liver cancer	6.97e-06	0.000106	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ALB—liver cancer	6.93e-06	0.000105	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—liver cancer	6.9e-06	0.000105	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HPGDS—liver cancer	6.9e-06	0.000105	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GOT2—liver cancer	6.87e-06	0.000104	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ALB—liver cancer	6.81e-06	0.000103	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTP1—liver cancer	6.79e-06	0.000103	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTM1—liver cancer	6.79e-06	0.000103	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ALB—liver cancer	6.73e-06	0.000102	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—HMOX1—liver cancer	6.7e-06	0.000102	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	6.68e-06	0.000102	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—liver cancer	6.6e-06	0.0001	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	6.55e-06	9.95e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PRKCE—liver cancer	6.53e-06	9.92e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP2E1—liver cancer	6.46e-06	9.81e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP1A1—liver cancer	6.44e-06	9.78e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—liver cancer	6.43e-06	9.77e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HPGDS—liver cancer	6.43e-06	9.77e-05	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—liver cancer	6.41e-06	9.74e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	6.38e-06	9.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	6.36e-06	9.67e-05	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	6.36e-06	9.66e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	6.31e-06	9.59e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.25e-06	9.5e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTM1—liver cancer	6.24e-06	9.49e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PSMD10—liver cancer	6.21e-06	9.44e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PSMA4—liver cancer	6.21e-06	9.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	6.17e-06	9.37e-05	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—RAF1—liver cancer	6.16e-06	9.36e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PSMA4—liver cancer	6.15e-06	9.34e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PSMD10—liver cancer	6.15e-06	9.34e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	6.14e-06	9.32e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CB—liver cancer	6.12e-06	9.3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—RAF1—liver cancer	6.09e-06	9.25e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GOT2—liver cancer	6.04e-06	9.18e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYCS—liver cancer	6.04e-06	9.18e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	6.02e-06	9.15e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—MTHFR—liver cancer	6e-06	9.12e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GOT2—liver cancer	5.98e-06	9.08e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GOT1—liver cancer	5.93e-06	9e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GGT1—liver cancer	5.93e-06	9e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—liver cancer	5.92e-06	9e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP1A1—liver cancer	5.92e-06	8.99e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TGFB1—liver cancer	5.9e-06	8.97e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARA—liver cancer	5.89e-06	8.95e-05	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—liver cancer	5.86e-06	8.91e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—liver cancer	5.86e-06	8.91e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CPT1B—liver cancer	5.85e-06	8.88e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GLUL—liver cancer	5.85e-06	8.88e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PSMA4—liver cancer	5.73e-06	8.7e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PSMD10—liver cancer	5.73e-06	8.7e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—H2AFX—liver cancer	5.69e-06	8.65e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP2E1—liver cancer	5.68e-06	8.63e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NR1H4—liver cancer	5.64e-06	8.57e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP2E1—liver cancer	5.62e-06	8.54e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GOT2—liver cancer	5.57e-06	8.47e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	5.56e-06	8.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA3—liver cancer	5.54e-06	8.42e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—MTHFR—liver cancer	5.52e-06	8.38e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—liver cancer	5.47e-06	8.3e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—liver cancer	5.46e-06	8.3e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—liver cancer	5.44e-06	8.26e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—liver cancer	5.43e-06	8.25e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARA—liver cancer	5.41e-06	8.23e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	5.36e-06	8.14e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	5.33e-06	8.1e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTP1—liver cancer	5.32e-06	8.09e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYCS—liver cancer	5.32e-06	8.07e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—RAF1—liver cancer	5.3e-06	8.05e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYCS—liver cancer	5.26e-06	7.99e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HMOX1—liver cancer	5.25e-06	7.98e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2E1—liver cancer	5.24e-06	7.96e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GOT1—liver cancer	5.22e-06	7.92e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GGT1—liver cancer	5.22e-06	7.92e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTHFR—liver cancer	5.16e-06	7.84e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GGT1—liver cancer	5.16e-06	7.84e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GOT1—liver cancer	5.16e-06	7.84e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TERT—liver cancer	5.15e-06	7.82e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	5.11e-06	7.77e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	5.1e-06	7.75e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA4—liver cancer	5.07e-06	7.7e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—liver cancer	5.06e-06	7.69e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CG—liver cancer	5.04e-06	7.66e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—liver cancer	5.02e-06	7.63e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—RAF1—liver cancer	4.94e-06	7.51e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA2—liver cancer	4.94e-06	7.51e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYCS—liver cancer	4.9e-06	7.45e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTM1—liver cancer	4.89e-06	7.43e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARG—liver cancer	4.87e-06	7.4e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.86e-06	7.39e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—liver cancer	4.86e-06	7.38e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GGT1—liver cancer	4.81e-06	7.31e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GOT1—liver cancer	4.81e-06	7.31e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA1—liver cancer	4.77e-06	7.24e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	4.76e-06	7.24e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	4.73e-06	7.18e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NAT2—liver cancer	4.71e-06	7.16e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTP1—liver cancer	4.68e-06	7.12e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—liver cancer	4.65e-06	7.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP1A1—liver cancer	4.64e-06	7.05e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTP1—liver cancer	4.64e-06	7.04e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CG—liver cancer	4.64e-06	7.04e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HMOX1—liver cancer	4.62e-06	7.02e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HMOX1—liver cancer	4.57e-06	6.95e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALDOB—liver cancer	4.52e-06	6.86e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARG—liver cancer	4.47e-06	6.8e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—liver cancer	4.44e-06	6.75e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CD—liver cancer	4.43e-06	6.74e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—liver cancer	4.38e-06	6.65e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	4.34e-06	6.6e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APC—liver cancer	4.34e-06	6.59e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MTHFR—liver cancer	4.32e-06	6.57e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTP1—liver cancer	4.32e-06	6.57e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CRABP1—liver cancer	4.31e-06	6.55e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	4.31e-06	6.55e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTM1—liver cancer	4.31e-06	6.54e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HMOX1—liver cancer	4.26e-06	6.47e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTM1—liver cancer	4.26e-06	6.47e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARA—liver cancer	4.24e-06	6.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.2e-06	6.38e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—liver cancer	4.1e-06	6.23e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1A1—liver cancer	4.08e-06	6.2e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BRAF—liver cancer	4.08e-06	6.19e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CD—liver cancer	4.08e-06	6.19e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1A1—liver cancer	4.04e-06	6.14e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—liver cancer	4.02e-06	6.11e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTM1—liver cancer	3.97e-06	6.03e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CB—liver cancer	3.87e-06	5.87e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CD—liver cancer	3.81e-06	5.79e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.81e-06	5.79e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MTHFR—liver cancer	3.8e-06	5.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SERPINE1—liver cancer	3.77e-06	5.73e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HPGDS—liver cancer	3.77e-06	5.72e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MTHFR—liver cancer	3.77e-06	5.72e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1A1—liver cancer	3.76e-06	5.72e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARA—liver cancer	3.73e-06	5.67e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—liver cancer	3.73e-06	5.67e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARA—liver cancer	3.69e-06	5.61e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CG—liver cancer	3.63e-06	5.52e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CB—liver cancer	3.55e-06	5.4e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.55e-06	5.39e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MTHFR—liver cancer	3.51e-06	5.33e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARG—liver cancer	3.51e-06	5.33e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARA—liver cancer	3.44e-06	5.23e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RAF1—liver cancer	3.4e-06	5.17e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PSMD10—liver cancer	3.36e-06	5.1e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PSMA4—liver cancer	3.36e-06	5.1e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTOR—liver cancer	3.32e-06	5.05e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CB—liver cancer	3.32e-06	5.05e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GOT2—liver cancer	3.27e-06	4.96e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	3.2e-06	4.87e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CG—liver cancer	3.2e-06	4.86e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CD—liver cancer	3.19e-06	4.85e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CG—liver cancer	3.16e-06	4.81e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—liver cancer	3.15e-06	4.79e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1B—liver cancer	3.12e-06	4.74e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARG—liver cancer	3.09e-06	4.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2E1—liver cancer	3.07e-06	4.67e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARG—liver cancer	3.05e-06	4.64e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—liver cancer	3.05e-06	4.63e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CG—liver cancer	2.95e-06	4.48e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CTNNB1—liver cancer	2.95e-06	4.48e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.9e-06	4.4e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1A—liver cancer	2.88e-06	4.37e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYCS—liver cancer	2.87e-06	4.37e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARG—liver cancer	2.85e-06	4.32e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GGT1—liver cancer	2.82e-06	4.28e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GOT1—liver cancer	2.82e-06	4.28e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CD—liver cancer	2.81e-06	4.27e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CB—liver cancer	2.78e-06	4.23e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CD—liver cancer	2.78e-06	4.23e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—liver cancer	2.77e-06	4.21e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—liver cancer	2.75e-06	4.17e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CD—liver cancer	2.59e-06	3.94e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—liver cancer	2.57e-06	3.9e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—liver cancer	2.56e-06	3.89e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTP1—liver cancer	2.53e-06	3.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMOX1—liver cancer	2.5e-06	3.8e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CB—liver cancer	2.45e-06	3.72e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CB—liver cancer	2.42e-06	3.68e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—liver cancer	2.39e-06	3.63e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—liver cancer	2.38e-06	3.62e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—liver cancer	2.36e-06	3.58e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTM1—liver cancer	2.33e-06	3.54e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CB—liver cancer	2.26e-06	3.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1A1—liver cancer	2.21e-06	3.35e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—liver cancer	2.21e-06	3.35e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—liver cancer	2.17e-06	3.29e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTHFR—liver cancer	2.06e-06	3.13e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—liver cancer	2.03e-06	3.08e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARA—liver cancer	2.02e-06	3.07e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—liver cancer	1.92e-06	2.92e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—liver cancer	1.87e-06	2.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—liver cancer	1.79e-06	2.73e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—liver cancer	1.77e-06	2.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CG—liver cancer	1.73e-06	2.63e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—liver cancer	1.7e-06	2.58e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARG—liver cancer	1.67e-06	2.53e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—liver cancer	1.66e-06	2.51e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CD—liver cancer	1.52e-06	2.31e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—liver cancer	1.5e-06	2.28e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—liver cancer	1.49e-06	2.27e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—liver cancer	1.48e-06	2.25e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—liver cancer	1.39e-06	2.11e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—liver cancer	1.38e-06	2.09e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CB—liver cancer	1.32e-06	2.01e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—liver cancer	1.22e-06	1.85e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—liver cancer	1.21e-06	1.83e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—liver cancer	1.13e-06	1.71e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—liver cancer	8.07e-07	1.23e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—liver cancer	6.6e-07	1e-05	CbGpPWpGaD
